Karimi, Y., Ghesquieres, H., Jurczak, W., Cheah, C. Y., Clausen, M. R., Lugtenburg, P., Cunningham, D., Do, Y. R., Lewis, D. J., Gasiorowski, R., Kim, T. M., van der Poel, M., Poon, M. L., Feldman, T., Linton, K. M., Sureda, A., Hutchings, M., Stirner, M. C., Liu, Y., … Thieblemont, C. (2023). POSTER: ABCL-500 Longer Follow-Up Reaffirms Subcutaneous Epcoritamab Induces Deep and Durable Complete Remissions in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Updated Results From the Pivotal EPCORE NHL-1 Trial. Clinical Lymphoma Myeloma and Leukemia, 23, S203. https://doi.org/10.1016/s2152-2650(23)00718-8
Subjects:
Lymphoid Neoplasms
(OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy
(OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1016/s2152-2650(23)00718-8
Publication Date:
Data Source:
OpenAlex
Source Link: